(PDF) Development and Validation of an All-Cause Mortality

Development and Validation of an All-Cause Mortality Risk Score in Type 2 DiabetesThe Hong Kong Diabetes Registry

Archives of Internal Medicine

doi 10.1001/archinte.168.5.451

Full Text

Abstract

Available in full text

Date

March 10, 2008

Authors

Publisher

American Medical Association (AMA)

Related search

Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry

Internal Medicine

English

Television Viewing and Risk of Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality

JAMA - Journal of the American Medical Association

English

Metabolic Syndrome Increases All-Cause and Vascular Mortality: The Hong Kong Cardiovascular Risk Factor Study

Clinical Endocrinology

English

Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database

Internal Medicine

Specialized Nursing

English

Development and Validation of a New Diabetes Risk Score in Guyana

Diabetes Therapy

Internal Medicine

English

The Interactive Effects of Type 2 Diabetes Mellitus and Schizophrenia on All-Cause Mortality: The Fremantle Diabetes Study

Journal of Diabetes and its Complications

Internal Medicine

English

Target Values of Cardiovascular Risk Factors Are Not Associated With All-Cause Mortality in Patients With Type 2 Diabetes Mellitus

Multidisciplinary

English

Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated With a Reduction in All-Cause Mortality

Cardiovascular Medicine

English

Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated With a Reduction in All Cause Mortality

Artery Research

English